Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tosedostat

EU orphan designation number: EU/3/09/659   
Active ingredient: Tosedostat
Indication: Treatment of acute myeloid leukaemia
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Orphan designation EMEA/OD/028/09 (2009)6033 of 24/07/2009
26/03/2015 Change of name and/or address of sponsor
13/05/2015 Transfer of orphan designation EMA/OD/028/09/T/01 (2015)3243 of 07/05/2015
22/05/2017 Change of name and/or address of sponsor